Roughly 1 in 3 adults has metabolic dysfunction–associated steatotic liver disease, or MASLD. A doctor outlines how to detect and slow the condition early.

Though it is predicted to become a top cause of organ damage and liver transplants within this decade, treatments for nonalcoholic fatty liver disease, or NAFLD, have stalled for a simple reason: It ...

What you need to know A 58 year old man presents to his general practitioner (GP) to discuss recent blood test results after ...

Fatty liver disease has become one of the most common liver problems across the world. Two forms stand out: non-alcoholic ...

Non alcoholic fatty liver affects approximately one in three adults or children in India, as per the data published in PubMed Central. It is a silently growing metabolic crisis that often develops ...

Doctors can accurately predict a person's risk of fatty liver disease as early as 16 years before symptoms develop, a new study says. A blood test looking for five specific proteins can predict ...

Fatty liver disease and insulin resistance form a dangerous cycle, leading to inflammation and possibly NASH. Dr Brijmohan Arora says early signs may appear physically, including a hard belly paunch, ...

Non-alcoholic fatty liver disease (NAFLD) is among the most prevalent chronic liver disorders worldwide and can sometimes lead to severe conditions like cirrhosis and hepatocellular carcinoma. As such ...

It’s often, “silent” – meaning it rarely presents with symptoms. Until it is severe. It is projected to be the number one cause of liver transplantation in the United States by the year 2030. And it’s ...

Nonalcoholic fatty liver disease (NAFLD) is a medical condition where fat builds up in your liver. It’s a very common condition found in about a quarter of all American adults. But when it happens ...